ACTRN12609000401257已完成未知
A randomised controlled trial of 24 weeks of moderate-intensity exercise training versus stretching among overweight males with Barrett's oesophagus to assess the effects on biochemical and hormonal factors associated with oesophageal adenocarcinoma development.
Burns, Trauma and Critical Care Research Centre, School of Medicine, University of Queensland0 个研究点目标入组 120 人开始时间: 2009年6月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- Male
入选标准
- •Barrett's Oesophagus confirmed via the presence of intestinal metaplasia on biopsy and an abnormal appearance of the distal oesophagus via endoscopy.
- •Overweight or obese (Body mass index 25-34.99kg/m2)
- •Performing less than 60 min of moderate-intensity exercise per week for the previous 12 weeks.
- •No loss or gain of >5kg of body weight during the previous 6 months.
排除标准
- •Serious medical impairments including: heart disease, lung disease, neurological disease, uncontrolled hypertension, diabetes, cancer, orthopaedic injuries.
研究者
相似试验
招募中
4 期
Assessing the differential benefits of various anti diabetic agents among individuals with novel subtypes of diabetesCTRI/2021/11/037753SV Private Limited
已完成
3 期
REGiM: Prolonged treatment with darbepoetin alpha (EPO), with/without recombinant human granulocyte colony stimulating factor (G-CSF), versus best supportive care in patients with low-risk myelodysplastic syndromes (MDS)Topic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (acute myeloid)Myelodysplastic syndromesCancerISRCTN65652441Barts and The London NHS Trust (UK)1,200
已完成
不适用
Weight Loss Maintenance in AdultsObesityISRCTN35774128Cardiff University (UK)950
已完成
3 期
A multicenter, study to assess theefficacy and safety of everolimusplus reduced tacrolimus compared to standard tacrolimusin recipients undergoing liver transplantation.CTRI/2014/02/004395ovartis Healthcare Private Limited29
进行中（未招募）
1 期
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver TransplantsEUCTR2010-024527-25-ITovartis Farma SpA470